Status:
COMPLETED
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
Lead Sponsor:
Astellas Pharma Inc
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.
Detailed Description
The purpose of this randomized, double-blind, placebo-controlled, parallel-group, multi-center designed trial is to determine the safety and efficacy of tacrolimus inhalation aerosol in subjects with ...
Eligibility Criteria
Inclusion
- Diagnosis of persistent asthma for at least 6 months
- Require use of beta-agonists at least four times per week
Exclusion
- Diagnosis of chronic obstructive pulmonary disease (COPD)
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00116103
Start Date
June 1 2005
End Date
April 1 2006
Last Update
June 7 2012
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Scottsdale, Arizona, United States, 85251
2
Encinitas, California, United States, 92024
3
Los Angeles, California, United States, 90025
4
San Diego, California, United States, 92120